EMEA-003006-PIP01-21

Table of contents

Key facts

Active substance
Cetrelimab
Therapeutic area
Oncology
Decision number
P/0289/2021
PIP number
EMEA-003006-PIP01-21
Pharmaceutical form(s)
All pharmaceutical forms
Condition(s) / indication(s)
Treatment of urothelial carcinoma
Route(s) of administration
All routes of administration
Contact for public enquiries
Janssen-Cilag International NV

E-mail: contact@janssen-emea.com
Tel.: +32 14602111

Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating